Medication info

Aliphen Primix Injection (Ibuprofen)

Prescription medicationInjections
Ingredient · strength
Ibuprofen›400mg / 100mL
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
A colorless or light yellow liquid filled in a clear plastic vial.
Packaging
100milliliters/vial, 200milliliters/vial
Approval status
Active

MFDS item code 202202311 · Notified 2022.06.02

Summary

Main use
Adjunctive therapy with opioid analgesics for moderate to severe pain; relief of fever
Who uses it
Adults · Children
Adult dosage
This medicine should be administered at the minimum effective dose that meets each patient's treatment goals and for the shortest possible duration. After the initial administration, adjust the dose and frequency of administration appropriately according to the patient's condition. This medicine is a premixed preparation and must be administered as supplied without dilution. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the prescribed dose; do not subdivide. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time should be at least 30 minutes. (2) Antipyresis Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time should be at least 30 minutes.
Children's dosage
6 months to under 12 years: Administer 10mg/kg per dose initially (maximum 400mg) intravenously every 4~6 hours as needed; the administration time should be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time should be at least 10 minutes. Up to 2,400mg per day may be administered.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive therapy with opioid analgesics for moderate to severe pain; relief of fever

  • Pain
View approved original text

This medication is used as an adjunct therapy to control moderate to severe pain with opioid analgesics. Additionally, it has antipyretic effects that help reduce discomfort during fever. It is effective in managing both pain and fever, thus improving the patient's discomfort.

Dosage and Administration

Adult dosage

This medicine should be administered at the minimum effective dose that meets each patient's treatment goals and for the shortest possible duration. After the initial administration, adjust the dose and frequency of administration appropriately according to the patient's condition. This medicine is a premixed preparation and must be administered as supplied without dilution. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the prescribed dose; do not subdivide. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time should be at least 30 minutes. (2) Antipyresis Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time should be at least 30 minutes.

Children's dosage

6 months to under 12 years: Administer 10mg/kg per dose initially (maximum 400mg) intravenously every 4~6 hours as needed; the administration time should be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the administration time should be at least 10 minutes. Up to 2,400mg per day may be administered.

Precautions

This medication may increase the risk of cardiovascular issues such as myocardial infarction and stroke in patients with cardiovascular disease or risk factors. The risk may be further heightened with long-term use at high doses, thus caution is necessary. This drug can lead to serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforations, with elderly patients or long-term users being at greater risk. Patients with a history of gastrointestinal disorders or severe conditions affecting blood, liver, kidneys, or heart should not use this medication. Patients with bronchial asthma or hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs should also avoid it. Usage during late pregnancy is contraindicated due to the risk of patent ductus arteriosus closure for the fetus. Patients with blood abnormalities, tendency to bleed, liver or kidney dysfunction, heart failure, hypertension, or a history of hypersensitivity should use this medication cautiously. This drug may reduce the cardioprotective effect of aspirin when taken together and could increase the risk of gastrointestinal bleeding. Various adverse reactions may occur during the use of this medication, such as headaches, nausea, vomiting, skin rashes, respiratory distress, blood pressure changes, or renal function abnormalities, so if any unusual symptoms arise, consult a healthcare professional immediately. It is important not to exceed the recommended dose and not to take with other non-steroidal anti-inflammatory drugs simultaneously. Patients with hypertension or heart failure should closely monitor blood pressure and fluid status when taking this medication. Patients with impaired renal or liver function should consult a physician before use and undergo regular function tests. This medication can cause severe allergic reactions and severe skin reactions; therefore, if skin rash or respiratory distress occurs, discontinue the medication immediately. During pregnancy, especially after 20 weeks, there is a risk of fetal kidney dysfunction and oligohydramnios, so it should only be used short-term and at the minimum effective dose when absolutely necessary. In breastfeeding, this medication can be secreted in breast milk and may cause adverse reactions in infants; therefore, breastfeeding interruption or medication cessation should be considered. It is advisable not to use it in children under 6 months of age as safety and effectiveness have not been established. Elderly patients should have their dosages adjusted and be closely monitored for adverse reactions due to decreased bodily function. In cases of overdose, symptoms such as dizziness, nausea, abdominal pain, liver function abnormalities, renal failure, respiratory distress, and hypotension may occur; seek medical help immediately if symptoms occur.

Side effects

Shock, anaphylactic reaction, mimicry concern, chills, dyspnea, hypotension, decreased hematocrit, decreased hemoglobin, anemia, aplastic anemia, hemolytic anemia, agranulocytosis, granulocytopenia, leukopenia, thrombocytopenia, impaired platelet function, eosinophilia, peptic ulcer, gastrointestinal ulcer, gastrointestinal bleeding, perforation, ulcerative colitis, hematochezia, gastritis, pancreatitis, hematemesis, Crohn's disease, loss of appetite, nausea, vomiting, abdominal pain, dyspepsia, diarrhea, gastric discomfort, upper abdominal pain, thirst, stomatitis, abdominal distension, oral ulcer, constipation, melena, skin and mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitive reaction, drug rash accompanied by eosinophilia and systemic syndrome, angioedema, vesicular dermatitis, erythema multiforme, papular rash, skin redness, blisters, rash, exfoliative dermatitis, acute generalized pustular dermatosis, hepatitis, jaundice, liver dysfunction, liver impairment, hypersensitivity, anaphylaxis, asthma attack, urticaria, eczema, purpura, rash, pruritus, asthma, bronchoconstriction, dyspnea, wheezing, scotoma, hearing loss, tinnitus, taste disturbance, dizziness, drowsiness, lightheadedness, depression, headache, cerebrovascular accident, irritability, aseptic meningitis, hypertension, palpitations, heart failure, myocardial infarction, angina, acute renal failure, oliguria, hematuria, proteinuria, elevated serum creatinine, hyperkalemia, interstitial nephritis, nephritic syndrome, renal papillary necrosis, decreased urine output, generalized edema, shortness of breath, lethargy, Conn's syndrome, orbital edema, facial edema, malaise, fever, epistaxis, edema, peripheral edema, nausea, abdominal distension, headache, hemolysis, drowsiness, peripheral edema, urinary dysfunction, anemia, decreased hemoglobin, dyspepsia, wound hemolysis, abdominal discomfort, cough, hypokalemia, eosinophilia, hypoalbuminemia, neutropenia, increased hematuria, hypernatremia, hypertension, hypoalbuminemia, hypotension, diarrhea, bacterial pneumonia, elevated serum LDH, increased platelets, bacteremia, increased white blood cell count, injection site pain, nausea, dizziness, loss of consciousness, convulsions, metabolic acidosis, respiratory depression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid contact with air and kept at a temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's efficacy over time.

Appearance and packaging

Appearance

A colorless or light yellow liquid filled in a clear plastic vial.

Package unit

100milliliters/vial, 200milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.